ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Female sexual interest drug reaches tipping point with Phase III plans
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="sammmy" data-source="post: 235718" data-attributes="member: 38594"><p>The first drug for female hypo-active disorder, flinbanserin (Addyi), has plummeted in sales because the insane high price does not match the minor benefits and not many women have the financial resources to get on it, only to find out that the benefit is minimal or nonexistent.</p><p></p><p>The incoming alternatives Lybrido and Lybridos are also questionable. Women already use low concentration testosterone creams for desire. Viagra creates blood flow down there but this is not necessarily a burst of desire (as men know very well, erection is not libido). Buspirone has been touted for long time to "increase desire" and counteract the anorgasmia from SSRIs but it hasn't picked on that, which means that the real benefit is either small or the dose required is too high leading to side effects. I've overdosed on Buspirone and it did reduce the time to reach orgasm (I have delayed ejaculation due to nervous system damage) but the necessary effective dose made me vomit. Lower doses did not work.</p><p></p><p>Added to the fact, that I expect all those to be with severely inflated prices, we will see just another example of overpriced "miracle libido pills" that will go down the drain because of foolish capitalistic greed.</p></blockquote><p></p>
[QUOTE="sammmy, post: 235718, member: 38594"] The first drug for female hypo-active disorder, flinbanserin (Addyi), has plummeted in sales because the insane high price does not match the minor benefits and not many women have the financial resources to get on it, only to find out that the benefit is minimal or nonexistent. The incoming alternatives Lybrido and Lybridos are also questionable. Women already use low concentration testosterone creams for desire. Viagra creates blood flow down there but this is not necessarily a burst of desire (as men know very well, erection is not libido). Buspirone has been touted for long time to "increase desire" and counteract the anorgasmia from SSRIs but it hasn't picked on that, which means that the real benefit is either small or the dose required is too high leading to side effects. I've overdosed on Buspirone and it did reduce the time to reach orgasm (I have delayed ejaculation due to nervous system damage) but the necessary effective dose made me vomit. Lower doses did not work. Added to the fact, that I expect all those to be with severely inflated prices, we will see just another example of overpriced "miracle libido pills" that will go down the drain because of foolish capitalistic greed. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Female sexual interest drug reaches tipping point with Phase III plans
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top